General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | -1.35 | -1.06 | 0.29 | 21.48% |
2024-02-22 | 2023-12 | -1.47 | -1.46 | 0.01 | 0.68% |
2023-11-09 | 2023-09 | -1.52 | -1.38 | 0.14 | 9.21% |
2023-08-03 | 2023-06 | -1.32 | -1.4 | -0.08 | -6.06% |
2023-05-04 | 2023-03 | -1.41 | -1.17 | 0.24 | 17.02% |
2023-02-23 | 2022-12 | -1.4 | -1.4 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-28 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-06 | Chardan Capital | Upgrade | Buy | Buy |
2023-08-06 | Canaccord Genuity | Upgrade | Buy | Buy |
2023-08-06 | Barclays | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-03 | BASTA JAMES EDMUND | General Counsel | 81.57K | Sale |
2023-10-30 | BHANJI MUNA | Director | 12.00K | Sale |
2024-03-03 | CLARK ELIANA | Chief Technology Officer | 71.47K | Sale |
2023-06-13 | COHEN FREDERICK E. M.D. PH.D. | Director | 41.72K | Stock Award(Grant) |
2023-06-13 | CROWLEY JOHN FRANCIS | Director | 11.72K | Stock Award(Grant) |
2024-02-29 | GODDARD GLENN G | Chief Financial Officer | 69.21K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | ARK Investment Management, LLC | 9.95M | 314.58M | 11.24% |
2023-06-29 | Vanguard Group Inc | 8.19M | 333.79M | 9.25% |
2023-06-29 | Blackrock Inc. | 8.05M | 328.48M | 9.10% |
2023-06-29 | State Street Corporation | 3.49M | 142.44M | 3.95% |
2023-06-29 | Nikko Asset Management Americas, Inc. | 3.39M | 138.43M | 3.84% |
2023-06-29 | Sumitomo Mitsui Trust Holdings, Inc. | 3.39M | 138.43M | 3.84% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | ARK ETF Tr-ARK Innovation ETF | 6.78M | 214.49M | 7.67% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.62M | 107.02M | 2.97% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.16M | 88.16M | 2.44% |
2023-09-29 | ARK ETF Tr-ARK Genomic Revolution ETF | 2.03M | 64.22M | 2.30% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 75.44M | 2.27% |
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.62M | 60.77M | 1.83% |
Anyone knows time $NTLA CeO will be on CNBC?
Price target changes to $250 by GS after ceo speaks
When $NTLA just surged to 175 …bears pissed in their pants & shorters and no one had the balls to short this stock
According to WSJ: great news $NTLA Shares outstanding 68 M. public float 60 M. Shares short 5 M. We apes own it! ️
All bears that shorted it today btw 155 to 175 just got burnt 🥵 🥵🥵🥵🥵
Guys pls immediately set very high sell limits. Mine at $500. And remove all stop loss from ur tickets and watch it cross $250 today!!! $NTLA
We have been trending for past 5 days ️️️️
Now that’s what I’m talking! And pls if you are in a tough financial situation, please please take my advise and start selling your shares w scaling loss. Now!!! Don’t wait and leave half your shares to decide tomorrow. View my below posts how to scale thru loss
For those in high loss situations. Let’s say if you bought 500 shares. I would sell 100 now. I would sell 100 more during power hour (3-4) irregardless price moves up or down! This way you minimize loss & hold 300 shares for tomorrow. And tomorrow you judge situation again, but for time being some reprieve from house calls and Margin calls. Hope this helps
But as I’ve stated before, if u have a house call, margin call, or bought shares from margin, pls pls this is a time to exit w strategy & scale ur losses as stock doing pretty good today. Don’t wait for tomorrow or After hours. My sincere advice to those that are in deep water or even shallow.
Another catalyst to jump price $NTLA above $300 …a strong merger w big pharma. Anything can happen! It’s all good from here, Believe in the company
Don’t be scared if price goes down Bc w long wknd coming, many will take profits today & tomorrow. But also, shorts will start to cover for profits so price will move upwards
And oh! You folks (bulls) must share positive news of $ NTLA on other boards, platforms, friends, social media to gain greater momentum and that will definitely push the volumne. ️️️️️️️
$NTLA has multiple studies in phases. So any news or positive outcome or higher price target is a definite catalyst for stock to shoot.
Big investors, big institutions have invested in $NTLA easily above $180 price. Do you think they all are idiots? Let Nasdaq come into solid green & see $NTLA fly! Rip bear ass. Toast their moms. Holding at $165 on a red day after price offering is awesome! And don’t worry about insiders (employees) selling shares for profits. They are suppose to do that. But they were stupid not to sell at peak, most sold after offering!
Guys this is what these shorters did w $CERE this week. Made me sell a position of $33 to $27 creating fear after price offering. I lost 27k. And next day, price stabilized to $29 and it’s going up everyday. Bears said $CERE will hit under 5. For those that don’t know, $CERE is also pharma and working on drug for Parkinson. plus many others in trial.
I set sell limit $500 gtc. NOT even gonna look at it anymore ️️️
holy terrific $NTLA breaking $165 when Nasdaq is red & low I want some bear meat now🥲🥲
Boy oh boy! We R $NTLA trending! Hold your horses & buy buy buy. Remove all sell loss orders & set very high sell prices now! I’ve been telling you all for 2 days, don’t listen to Bears bs This gonna see highs of $25O. Just lef Nasdaq come into strong green. Bears ass will split into trillions
What is VWAP? What it indicates?
Some winning perspectives $NTLA from last 4 months. March high 80. April high upper 80’s. May high was $78. June again 80+ and then hit $202! So now even if offering goes as low as 125, which it is not. Offering btw 140-160. No way, $NTLA will go below 80 or 100 or 125! It’s only going to trend higher & higher After successful phase 1 study and another phase 2 study just around the corner. Plus $NTLA has partnership with Novartis